West, who was ousted in 2012, conceded that it would be an uphill race.
About TRNS Washington Desk
View all posts by TRNS Washington DeskFor Immediate Release
By Ed Zuckerman
-
Wednesday, June 19
Click on the date above for access to this exclusive TRNS feature. For Immediate Release is a daily compilation of press releases collected from the websites of nearly 2,000 federal agencies and national advocacy groups. They are selected because, in the opinion of the editor, they are newsworthy, provocative or they are just plain curious. [...]
Articles
-
Ethanol Subsidies Backfire As Farm Bill Looms
June 17, 2013
-
John Mica Fed Up With Amtrak Gourmet Menu
June 18, 2013
-
Poll: Obama’s Approval Dips By 8 Points
June 17, 2013
-
Time To Reexamine 2nd Amendment, Privacy
June 17, 2013
-
Biden Tells Lawmakers They’ll Regret Voting Against Gun Control
June 18, 2013
-
Poll: 47% Think White House Ordered IRS Targeting
June 18, 2013

NIH Teaming Up With Pharma Giants For New Treatments
The National Institute of Health announced Thursday that three pharmaceutical companies will be granting them access to industry compounds in an attempt to help the Institute spearhead new research into treatments for a wide variety of conditions.
“Americans are eagerly awaiting the next generation of cures and treatments to help them live longer and healthier lives,” Health and Human ServiceTo accelerate our nation’s therapeutic development process, it is essential that we forge strong, innovative, and strategic partnerships across government, academia and industry.”
The companies include AstraZeneca, Lilly and Pfizer and the NIH says that additional companies may eventually sign on. The compounds will be supplied to the NIH’s newly formed Natonal Center for Advancing Translational Sciences.
Tags: AstraZeneca, Lilly, NIH, Pfizer